CardieX Company Overview

CDX Overview

Technology and Healthcare

Market Cap : $19 Million @ 3.0 Cents Per Share
Cash on Hand : $5 Million +
Shares on Issue : 631 Million
Top 20 : Circa 60 percent ( Little bit hard to piece together without an updated Top 20)
Recent Capital Raising(s)
May 2018 : $5,000,000 @ 2 cents
December 2018 : $5,000,000 @ 3 cents

Current Revenue : $4 Million Per Annum

Craig Cooper & Director Niall Cairns
Have invested $4 Million into the company via C2 Ventures PTY During 2018

They now hold roughly %25 percent of all shares in the company.

Recent Board Changes and Restructure

DECEMBER 2017

Craig Cooper becomes CEO



JULY 2018

ZiHan Lin : Former executive @ Masimo, Inc (NASDAQ:MASIUS $5B ) to head of CardieX’s Asian strategy with a focus on the Chinese market and new wearable device technologies

Rhonda Welch : Former Johnson & Johnson executive to drive new strategic initiatives and reimbursement strategies

Doug Kurschinski : Promoted to Executive VP & Head of Global Sales of Atcor Medical division

Former CEO, Duncan Ross leaves the company

Here are a few slides from a recent Investor Presentation to give an overview of management and executive team. As you can see this is one highly credentialed board and team they have established.





A snapshot of the previous company history, restructure of the board, forward looking investments and initiatives dated November 30th.



Here I have put together a list of announcements with a timeline of events as they have unfolded since Craig came on board as the new CEO

MARCH 14TH 2018
CardieX ( Formerly AtCor ) Announces first steps in to major re-positioning of the company as a global health technology provider.



JULY 24TH 2018
Cardiex Reports Successful Initial Trial Results for Wearable Blood Pressure Sensor Technology with Blumio



OCTOBER 16TH 2018
CardieX Announces Major Acquisition of inHealth Medical Services



Audio Interview with Craig Cooper covering the inHealth acquisition, and a few other bits and pieces. A real straight up, no rubbish interview. extremely good listen!



NOVEMBER 1ST 2018
CardieX Partner Blumio Initiates Large Scale Clinical Trial







NOVEMBER 28TH 2018
CardieX Owned inHealth Partners with Kaiser Permanente



DECEMBER 6TH 2018
CardieX Successfully Closes Heavily Oversubscribed $5.5 Capital Raising



DECEMBER 12TH 2018
CardieX Signs Agreement for Wearable Sensor Development



DECEMBER 18TH 2018
CardieX inHealth Signs LOI with Global Electronics Company





Click here for latest Corporate Update With Investor Presso

As you can see its been a very busy couple of months for CardieX and the new team with great focus on executing there new strategy for the Company and Shareholders.

Sounds like we have alot to look forward to in 2019, with multiple catalysts in Q1.
I am looking forward to plenty of updates from company as things progress.


Hope you have all found this summary helpful and able to extract some value from summary of the last 12 months.

There is so much good information in all of these announcements, its pretty hard not to get excited for the future of CardieX.

This research is all my own, reading through many ASX announcements publicly available.

Please make sure you do your own research before making any investment decisions

Disclosure

I currently hold a position i have been accumulating since last year as ST/MT investment.

I also have a trading position, albeit small as buyers started jumping over me to get my fill

Cheers

Valve